Metraipolis › archive › dc_fe916d2a2a36

Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC) — Europe PMC PMID:42151561

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42151561
DOI
10.1038/s41416-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-01T14:25:22.782Z
SHA-256 of the archived text
614917d8ddfbb5cfa8647999885c58a36c57d9bb92234a910d7e92f515c449bb
Stable URL of this page
https://metraipolis.com/documento/dc_fe916d2a2a36

How to cite

Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC) — Europe PMC PMID:42151561 — Europe PMC (en), https://europepmc.org/article/MED/42151561 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe916d2a2a36 (Metraipolis archive dc_fe916d2a2a36, sha256 614917d8ddfbb5cfa8647999885c58a36c57d9bb92234a910d7e92f515c449bb)
BibTeX
@misc{dcfe916d2a2a36,
  title = {Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC) — Europe PMC PMID:42151561},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42151561},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe916d2a2a36; sha256 614917d8ddfbb5cfa8647999885c58a36c57d9bb92234a910d7e92f515c449bb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151561. Agents can read the archived copy with the MCP tool read_document.